Literature DB >> 8077727

Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis.

E Aurelius1, B Andersson, M Forsgren, B Sköldenberg, O Strannegård.   

Abstract

Sequential samples of serum and cerebrospinal fluid (CSF), from 9 patients with herpes simplex encephalitis (HSE), were analyzed for cytokines and soluble cytokine receptors. The response to herpes simplex virus was characterized by a vigorous compartmentalized immune response. The intrathecal response comprised three different phases: an acute stage (first week of illness), characterized by elevated CSF levels of interleukin (IL)-6 and interferon-gamma; an early convalescence stage (weeks 2-6 after onset of disease), associated with peaking levels of tumor necrosis factor-alpha and late markers of the specific T cell-mediated immune response, soluble IL-2 receptor, and soluble CD8 antigen (sCD8); and finally, a late convalescence stage, lasting months to years and associated with persistently increased levels of sCD8 in particular. These findings show the compartmentalization and kinetics of the inflammatory response in HSE and demonstrate persistence of the intrathecal inflammatory process, which may have implications for antiviral and antiinflammatory therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077727     DOI: 10.1093/infdis/170.3.678

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

Authors:  J R Lokensgard; S Hu; W Sheng; M vanOijen; D Cox; M C Cheeran; P K Peterson
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

3.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitis.

Authors:  Christopher D Conrady; Min Zheng; Nico van Rooijen; Douglas A Drevets; Derek Royer; Anthony Alleman; Daniel J J Carr
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

Review 6.  IL-1β: an important cytokine associated with febrile seizures?

Authors:  Hong-Mei Yu; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

7.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

8.  Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Anders Hjalmarsson; Fredrik Granath; Marianne Forsgren; Maria Brytting; Paul Blomqvist; Birgit Sköldenberg
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

Review 9.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

10.  Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection.

Authors:  Stephanie Wickham; John Ash; Thomas E Lane; Daniel J J Carr
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.